Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1997 1
1998 1
1999 1
2000 1
2003 2
2005 2
2006 3
2007 2
2008 5
2009 10
2010 5
2011 4
2012 5
2013 5
2014 5
2015 5
2017 1
2018 3
2019 1
2020 4
2021 5
2022 5
2023 6
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 variant-dependent inflammasome activation.
Teyssou E, Marot S, Gothland A, Malet I, Zafilaza K, Leducq V, Cocherie T, Todesco E, Soulié C, Marcelin AG, Calvez V. Teyssou E, et al. Among authors: malet i. J Infect. 2023 Jul;87(1):62-63. doi: 10.1016/j.jinf.2023.04.005. Epub 2023 Apr 13. J Infect. 2023. PMID: 37060923 Free PMC article. No abstract available.
A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import.
Boulay A, Quevarec E, Malet I, Nicastro G, Chamontin C, Perrin S, Henriquet C, Pugnière M, Courgnaud V, Blaise M, Marcelin AG, Taylor IA, Chaloin L, Arhel NJ. Boulay A, et al. Among authors: malet i. EMBO Mol Med. 2024 Nov;16(11):2918-2945. doi: 10.1038/s44321-024-00143-w. Epub 2024 Oct 2. EMBO Mol Med. 2024. PMID: 39358603 Free PMC article.
Evolution of viral quasispecies during SARS-CoV-2 infection.
Jary A, Leducq V, Malet I, Marot S, Klement-Frutos E, Teyssou E, Soulié C, Abdi B, Wirden M, Pourcher V, Caumes E, Calvez V, Burrel S, Marcelin AG, Boutolleau D. Jary A, et al. Among authors: malet i. Clin Microbiol Infect. 2020 Nov;26(11):1560.e1-1560.e4. doi: 10.1016/j.cmi.2020.07.032. Epub 2020 Jul 24. Clin Microbiol Infect. 2020. PMID: 32717416 Free PMC article.
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients.
Bruel T, Vrignaud LL, Porrot F, Staropoli I, Planas D, Guivel-Benhassine F, Puech J, Prot M, Munier S, Bolland WH, Soulié C, Zafilaza K, Lusivika-Nzinga C, Meledge ML, Dorival C, Molino D, Péré H, Yordanov Y, Simon-Lorière E, Veyer D, Carrat F, Schwartz O, Marcelin AG, Martin-Blondel G; ANRS 0003S CoCoPrev Study Group. Bruel T, et al. Med. 2023 Oct 13;4(10):664-667. doi: 10.1016/j.medj.2023.07.007. Med. 2023. PMID: 37837962 Free PMC article.
Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection.
Guihot A, Plu I, Soulié C, Rousseau A, Nakid-Cordero C, Dorgham K, Parizot C, Litvinova E, Mayaux J, Malet I, Quentric P, Combadière B, Combadière C, Bonduelle O, Adam L, Rosenbaum P, Beurton A, Hémon P, Debré P, Vieillard V, Autran B, Seilhean D, Charlotte F, Marcelin AG, Gorochov G, Luyt CE. Guihot A, et al. Among authors: malet i. Front Immunol. 2022 Apr 22;13:844727. doi: 10.3389/fimmu.2022.844727. eCollection 2022. Front Immunol. 2022. PMID: 35529881 Free PMC article.
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
Richetta C, Subra F, Malet I, Leh H, Charpentier C, Corona A, Collin G, Descamps D, Deprez E, Parissi V, Calvez V, Tramontano E, Marcelin AG, Delelis O. Richetta C, et al. Among authors: malet i. J Virol. 2022 Jul 27;96(14):e0067622. doi: 10.1128/jvi.00676-22. Epub 2022 Jun 27. J Virol. 2022. PMID: 35758669 Free PMC article.
The future of integrase inhibitors of HIV-1.
Malet I, Calvez V, Marcelin AG. Malet I, et al. Curr Opin Virol. 2012 Oct;2(5):580-7. doi: 10.1016/j.coviro.2012.08.005. Epub 2012 Sep 12. Curr Opin Virol. 2012. PMID: 22980926 Review.
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.
Marot S, Malet I, Leducq V, Zafilaza K, Sterlin D, Planas D, Gothland A, Jary A, Dorgham K, Bruel T; Sorbonne Université SARS-CoV-2 Neutralizing Antibodies Study Group; Burrel S, Boutolleau D, Schwartz O, Gorochov G, Calvez V, Marcelin AG. Marot S, et al. Among authors: malet i. Nat Commun. 2021 Feb 8;12(1):844. doi: 10.1038/s41467-021-21111-9. Nat Commun. 2021. PMID: 33558507 Free PMC article.
80 results